ArticleFrontiers in immunology2022

Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy.

Jianping Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.